Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004)
- PMID: 20438282
- PMCID: PMC5585775
Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004)
Abstract
Introduction: Early detection of breast cancer by screening mammography aims to increase treatment options and decrease mortality. Recent studies have shown inconsistent results in their investigations of the possible association between travel distance to mammography and stage of breast cancer at diagnosis.
Objective: The purpose of the study was to investigate whether geographic access to mammography screening is associated with the stage at breast cancer diagnosis.
Methods: Using the state's population-based cancer registry, all female residents of New Hampshire aged > or =40 years who were diagnosed with breast cancer during 1998-2004 were identified. The factors associated with early stage (stages 0 to 2) or later stage (stages 3 and 4) diagnosis of breast cancer were compared, with emphasis on the distance a woman lived from the closest mammography screening facility, and residence in rural and urban locations.
Results: A total of 5966 New Hampshire women were diagnosed with breast cancer during 1998-2004. Their mean driving distance to the nearest mammography facility was 8.85 km (range 0-44.26; 5.5 miles, range 0-27.5), with a mean estimated travel time of 8.9 min (range 0.0-42.2). The distribution of travel distance (and travel time) was substantially skewed to the right: 56% of patients lived within 8 km (5 miles) of a mammography facility, and 65% had a travel time of less than 10 min. There was no significant association between later stage of breast cancer and travel time to the nearest mammography facility. Using 3 categories of rural/urban residence based on Rural Urban Commuting Area classification, no significant association between rural residence and stage of diagnosis was found. New Hampshire women were more likely to be diagnosed with breast cancer at later stages if they lacked private health insurance (p<0.001), were not married (p<0.001), were older (p<0.001), and there was a borderline association with diagnosis during non-winter months (p=0.074).
Conclusions: Most women living in New Hampshire have good geographical access to mammography, and no indication was found that travel time or travel distance to mammography significantly affected stage at breast cancer diagnosis. Health insurance, age and marital status were the major factors associated with later stage breast cancer. The study contributes to an ongoing debate over geographic access to screening mammography in different states, which have given contradictory results. These inconsistencies in the rural health literature highlight a need to understand the complexity of defining rural and urban residence; to characterize more precisely the issues that contribute to good preventive care in different rural communities; and to appreciate the efforts already made in some rural states to provide good geographic access to preventive care. In New Hampshire, specific subgroups such as the uninsured and the elderly remain at greatest risk of being diagnosed with later stage breast cancer and may benefit from targeted interventions to improve early detection.
Similar articles
-
Rural-urban difference in female breast cancer diagnosis in Missouri.Rural Remote Health. 2015 Jul-Sep;15(3):3063. Epub 2015 Jul 29. Rural Remote Health. 2015. PMID: 26223824
-
Breast cancer stage at diagnosis: is travel time important?J Community Health. 2011 Dec;36(6):933-42. doi: 10.1007/s10900-011-9392-4. J Community Health. 2011. PMID: 21461957
-
Association between individual and geographic factors and nonadherence to mammography screening guidelines.J Womens Health (Larchmt). 2014 Aug;23(8):664-74. doi: 10.1089/jwh.2013.4668. Epub 2014 May 27. J Womens Health (Larchmt). 2014. PMID: 24865409 Free PMC article.
-
Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.PLoS One. 2022 Jul 19;17(7):e0271319. doi: 10.1371/journal.pone.0271319. eCollection 2022. PLoS One. 2022. PMID: 35853035 Free PMC article.
-
Mammography screening in Switzerland: limited evidence from limited data.Swiss Med Wkly. 2004 May 29;134(21-22):295-306. doi: 10.4414/smw.2004.10507. Swiss Med Wkly. 2004. PMID: 15243841 Review.
Cited by
-
Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status.Cancer Epidemiol. 2016 Aug;43:63-9. doi: 10.1016/j.canep.2016.06.011. Epub 2016 Jul 7. Cancer Epidemiol. 2016. PMID: 27394678 Free PMC article.
-
Rural-Urban Residence and Stage at Breast Cancer Diagnosis Among Postmenopausal Women: The Women's Health Initiative.J Womens Health (Larchmt). 2019 Feb;28(2):276-283. doi: 10.1089/jwh.2017.6884. Epub 2018 Sep 27. J Womens Health (Larchmt). 2019. PMID: 30230942 Free PMC article.
-
Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects - screening and sex.Wien Med Wochenschr. 2011 Mar;161(5-6):143-8. doi: 10.1007/s10354-011-0867-9. Epub 2011 Mar 7. Wien Med Wochenschr. 2011. PMID: 21360293
-
Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria.Breast Care (Basel). 2020 Dec;15(6):642-647. doi: 10.1159/000506389. Epub 2020 Mar 10. Breast Care (Basel). 2020. PMID: 33447239 Free PMC article.
-
Do mobile units contribute to spatial accessibility to mammography for uninsured women?Prev Med. 2020 Sep;138:106156. doi: 10.1016/j.ypmed.2020.106156. Epub 2020 May 29. Prev Med. 2020. PMID: 32473958 Free PMC article.
References
-
- American Cancer Society. Cancer facts & figures 2008. Atlanta: American Cancer Society; 2008.
-
- Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine. 2005;353:1784–1792. - PubMed
-
- Lee CH. Screening mammography: proven benefit, continued controversy. Radiologic Clinics of North America. 2002;40(3):395–407. - PubMed
-
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002;359(9310):909–919. - PubMed
-
- National Cancer Institute. [Accessed 29 May 2008];Screening mammograms: questions and answers. Fact sheet 5.28. (Online) no date. Available: http://www.cancer.gov/cancertopics/factsheet/Detection/screening-mammograms.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical